A citation-based method for searching scientific literature

Stina George Fernandes, Rebecca Dsouza, Gouri Pandya, Anuradha Kirtonia, Vinay Tergaonkar, Sook Y Lee, Manoj Garg, Ekta Khattar. Cancers (Basel) 2020
Times Cited: 10







List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
848
30

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
30

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
254
30

Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer.
Cong Chen, Peili Gu, Jian Wu, Xianyun Chen, Shuangshuang Niu, Hong Sun, Lijie Wu, Na Li, Junhui Peng, Shaohua Shi,[...]. Nat Commun 2017
41
30

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Jian Hu, Soyoon Sarah Hwang, Marc Liesa, Boyi Gan, Ergun Sahin, Mariela Jaskelioff, Zhihu Ding, Haoqiang Ying, Adam T Boutin, Hailei Zhang,[...]. Cell 2012
180
30

The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter.
Mounir El Maï, Kay-Dietrich Wagner, Jean-François Michiels, Damien Ambrosetti, Arnaud Borderie, Sandrine Destree, Valerie Renault, Nadir Djerbi, Marie-Josèphe Giraud-Panis, Eric Gilson,[...]. Cell Rep 2014
48
30

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
Andrew J Ramsay, Víctor Quesada, Miguel Foronda, Laura Conde, Alejandra Martínez-Trillos, Neus Villamor, David Rodríguez, Agnieszka Kwarciak, Cecilia Garabaya, Mercedes Gallardo,[...]. Nat Genet 2013
179
30

Inhibition of TRF1 Telomere Protein Impairs Tumor Initiation and Progression in Glioblastoma Mouse Models and Patient-Derived Xenografts.
Leire Bejarano, Alberto J Schuhmacher, Marinela Méndez, Diego Megías, Carmen Blanco-Aparicio, Sonia Martínez, Joaquín Pastor, Massimo Squatrito, Maria A Blasco. Cancer Cell 2017
30
30

Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2.
Julien Cherfils-Vicini, Charlene Iltis, Ludovic Cervera, Sabrina Pisano, Olivier Croce, Nori Sadouni, Balázs Győrffy, Romy Collet, Valérie M Renault, Martin Rey-Millet,[...]. EMBO J 2019
26
30

Reactivation of telomerase in cancer.
Semih Can Akincilar, Bilal Unal, Vinay Tergaonkar. Cell Mol Life Sci 2016
80
20

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
20

Genomic footprints of activated telomere maintenance mechanisms in cancer.
Lina Sieverling, Chen Hong, Sandra D Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M Braun, Isidro Cortés-Ciriano, Ruibin Xi, Rolf Kabbe,[...]. Nat Commun 2020
21
20

SENEBLOC, a long non-coding RNA suppresses senescence via p53-dependent and independent mechanisms.
Cheng Lin Xu, Ben Sang, Guang Zhi Liu, Jin Ming Li, Xu Dong Zhang, Lian Xin Liu, Rick F Thorne, Mian Wu. Nucleic Acids Res 2020
17
20


Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.
S E Artandi, S Chang, S L Lee, S Alson, G J Gottlieb, L Chin, R A DePinho. Nature 2000
834
20

Shelterin-Mediated Telomere Protection.
Titia de Lange. Annu Rev Genet 2018
206
20

Telomerase directly regulates NF-κB-dependent transcription.
Arkasubhra Ghosh, Gaye Saginc, Shi Chi Leow, Ekta Khattar, Eun Myong Shin, Ting Dong Yan, Marc Wong, Zhizhuo Zhang, Guoliang Li, Wing-Kin Sung,[...]. Nat Cell Biol 2012
208
20

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
287
20

The telomere syndromes.
Mary Armanios, Elizabeth H Blackburn. Nat Rev Genet 2012
547
20


Control of human telomere length by TRF1 and TRF2.
A Smogorzewska, B van Steensel, A Bianchi, S Oelmann, M R Schaefer, G Schnapp, T de Lange. Mol Cell Biol 2000
564
20

Telomeres and telomerase in cancer.
Steven E Artandi, Ronald A DePinho. Carcinogenesis 2010
488
20

Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
432
20

TRF2 protects human telomeres from end-to-end fusions.
B van Steensel, A Smogorzewska, T de Lange. Cell 1998
20

Extension of life-span by introduction of telomerase into normal human cells.
A G Bodnar, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright. Science 1998
20


Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
S L Weinrich, R Pruzan, L Ma, M Ouellette, V M Tesmer, S E Holt, A G Bodnar, S Lichtsteiner, N W Kim, J B Trager,[...]. Nat Genet 1997
780
20

Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells.
Xavier Darzacq, Nupur Kittur, Sujayita Roy, Yaron Shav-Tal, Robert H Singer, U Thomas Meier. J Cell Biol 2006
121
20

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
142
20

Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer.
A I Soder, S F Hoare, S Muir, J J Going, E K Parkinson, W N Keith. Oncogene 1997
154
20

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
R K Moyzis, J M Buckingham, L S Cram, M Dani, L L Deaven, M D Jones, J Meyne, R L Ratliff, J R Wu. Proc Natl Acad Sci U S A 1988
20

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
20

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres.
A M Jones, A D Beggs, L Carvajal-Carmona, S Farrington, A Tenesa, M Walker, K Howarth, S Ballereau, S V Hodgson, A Zauber,[...]. Gut 2012
77
20

Cryo-EM structure of substrate-bound human telomerase holoenzyme.
Thi Hoang Duong Nguyen, Jane Tam, Robert A Wu, Basil J Greber, Daniel Toso, Eva Nogales, Kathleen Collins. Nature 2018
87
20




Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Y Li, M Li, G Yao, N Geng, Y Xie, Y Feng, P Zhang, X Kong, J Xue, S Cheng,[...]. Cancer Gene Ther 2011
11
20

Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.
Ekta Khattar, Kyaw Ze Ya Maung, Chen Li Chew, Arkasubhra Ghosh, Michelle Meng Huang Mok, Pei Lee, Jun Zhang, Wei Hong Jeff Chor, Gökhan Cildir, Chelsia Qiuxia Wang,[...]. Nat Commun 2019
17
20

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
95
20

Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
Marcia Bellon, Abhik Datta, Megan Brown, Jean-Francois Pouliquen, Pierre Couppie, Mirdad Kazanji, Christophe Nicot. Int J Cancer 2006
59
20

Gemcitabine causes telomere attrition by stabilizing TRF2.
Chih-Hao Su, Wei-Chih Chu, Keng-Hsin Lan, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Shou-Dong Lee, Ying-Chieh Tsai, Wei-Ping Lee. Eur J Cancer 2012
10
20


Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence.
Kaori Fujita, Izumi Horikawa, Abdul M Mondal, Lisa M Miller Jenkins, Ettore Appella, Borivoj Vojtesek, Jean-Christophe Bourdon, David P Lane, Curtis C Harris. Nat Cell Biol 2010
67
20

miR-155 drives telomere fragility in human breast cancer by targeting TRF1.
Roberto Dinami, Cristiana Ercolani, Eleonora Petti, Silvano Piazza, Yari Ciani, Rosanna Sestito, Andrea Sacconi, Francesca Biagioni, Carlos le Sage, Reuven Agami,[...]. Cancer Res 2014
80
20

Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Kuniaki Nakanishi, Toshiaki Kawai, Fumiyuki Kumaki, Sadayuki Hiroi, Makio Mukai, Eiji Ikeda, Catherine Elaine Koering, Eric Gilson. Clin Cancer Res 2003
74
20

Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
Xiaolan Guo, Yibin Deng, Yahong Lin, Wilfredo Cosme-Blanco, Suzanne Chan, Hua He, Guohua Yuan, Eric J Brown, Sandy Chang. EMBO J 2007
170
20

Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression.
Hsiangling Teo, Sourav Ghosh, Hendrik Luesch, Arkasubhra Ghosh, Ee Tsin Wong, Najib Malik, Anthony Orth, Paul de Jesus, Anthony S Perry, Jeffrey D Oliver,[...]. Nat Cell Biol 2010
125
20

Elevated TRF2 in advanced breast cancers with short telomeres.
Malissa C Diehl, Michael O Idowu, Katherine N Kimmelshue, Timothy P York, Colleen K Jackson-Cook, Kristi C Turner, Shawn E Holt, Lynne W Elmore. Breast Cancer Res Treat 2011
27
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.